Results 71 to 80 of about 2,472,817 (358)
Biomarker Gene Identification for Breast Cancer Classification [PDF]
arXiv, 2021 BACKGROUND: Breast cancer has emerged as one of the most prevalent cancers among women leading to a high mortality rate. Due to the heterogeneous nature of breast cancer, there is a need to identify differentially expressed genes associated with breast cancer subtypes for its timely diagnosis and treatment.
arxiv
The Breast Journal, 2010 Pregnancy-related breast cancer (PBC) is one of the most common malignancies during pregnancy (approx. one in 3,000 pregnancies); up to 3% of breast cancers are diagnosed in pregnancy. As maternal age at the time of pregnancy continues to increase as the incidence of breast cancer, the incidence of PBC is expected to increase.
ROVERA, FRANCESCA ANGELA +7 more
openaire +5 more sources
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Molecular Oncology, EarlyView.Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini +11 more
wiley +1 more source
Predicting Cancer Treatments Induced Cardiotoxicity of Breast Cancer Patients [PDF]
arXiv, 2022 Cardiotoxicity induced by the breast cancer treatments (i.e., chemotherapy, targeted therapy and radiation therapy) is a significant problem for breast cancer patients. The cardiotoxicity risk for breast cancer patients receiving different treatments remains unclear.
arxiv
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Molecular Oncology, EarlyView.Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi +6 more
wiley +1 more source
Cancer Medicine, 2020 Purpose Previous studies provide inconsistent interpretations of the effect of inherited genetic factors on the survival and prognosis of patients with breast cancer. The aim of this study was to examine the effect of germline BRCA1 and BRCA2 mutation on
Fugui Ye +6 more
doaj +1 more source
Ten-year Survival Prediction for Breast Cancer Patients [PDF]
arXiv, 2019 This report assesses different machine learning approaches to 10-year survival prediction of breast cancer patients.
arxiv
Breast bruises and breast cancer [PDF]
Breast Cancer Research, 2015 While recently examining one of the early classic works on breast cancer epidemiology—Janet E. Lane-Claypon’s 1926 report to the United Kingdom Ministry of Health [1]—and its 1931 US counterpart [2], I was struck by one item in the list of commonplace “antecedent conditions”: breast bruises, a not uncommon occurrence.
openaire +4 more sources
Molecular Oncology, EarlyView.We quantified and cultured circulating tumor cells (CTCs) of 62 patients with various cancer types and generated CTC‐derived tumoroid models from two salivary gland cancer patients. Cellular liquid biopsy‐derived information enabled molecular genetic assessment of systemic disease heterogeneity and functional testing for therapy selection in both ...
Nataša Stojanović Gužvić +31 more
wiley +1 more source
PIWIL2 and PL2L60 (Cancer/Testis genes) Expression in Breast Cancer
Archives of Breast Cancer, 2014 Background: Cancer/testis antigens (CTAs) are members of a group of proteins which are normally expressed in testis germ cells and to a lesser extent in the ovaries.
Rezvan Esmaeili +4 more
doaj +1 more source